Adding coronary calcium to the assessment of conventional cardiovascular risk factors leads to substantial improvement in cardiovascular risk classification of asymptomatic men and women, according to a study presented at the RSNA on Wednesday afternoon.
Adding coronary calcium to the assessment of conventional cardiovascular risk factors leads to substantial improvement in cardiovascular risk classification of asymptomatic men and women, according to a study presented at the RSNA on Wednesday afternoon.
Strong associations were found between the extent of coronary calcium and the risk of coronary events, with hazard ratios up to 9.6 in men and up to 21.6 in women, said presenter of the study Dr. Rozemarijn Vliegenthart Proenca, a radiology resident at the University Medical Center Groningen in the Netherlands.
More than 2000 asymptomatic patients were assessed by electron-beam tomography to determine amounts of coronary calcium in this prospective population-based study. When coronary calcium was added to the Framingham risk model, reclassification was most substantial in subjects initially classified as intermediate risk.
In men, 65% of those originally classified as at an intermediate risk were reclassified when coronary calcium was added to the risk model. More than a third (38%) moved to the low-risk category, and 27% moved to the high-risk category.
In women, 66% of those originally classified as at an intermediate risk were reclassified when coronary calcium was added to the risk model. Nearly half (45%) moved to the low-risk category, and 21% moved to the high-risk category.
“The reclassification was based on the actual events,” Proenca said. “So the observed risks in the different categories were repopulated based on our risk model, our prediction model, and based on the actual events occurring in the risk categories.”
Other studies have just shown that a high calcium score can affect risk stratification in a population, but were not based on actual events, she said.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.